Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Perspectives on the FDA Review Process

August 17, 2010 7:46 am | by MDT | Articles | Comments

Should the FDA review process be more relaxed in favor of faster review times at the expense of potentially greater impact to the well-being of patients when a device does fail?

TOPICS:

Coordinate Measuring Machine Designed for Tooling Inspection

August 17, 2010 7:27 am | Werth, Inc. | Product Releases | Comments

Highly accurate inspection of tooling is exactly the application for which the new multi-sensor coordinate measuring machine, Werth VideoCheck V HA of Werth Messtechnik GmbH, was developed.

Pumps Provide Clean Air-Flow

August 17, 2010 7:23 am | Product Releases | Comments

Series 660/680 WOB-L Piston pumps from Thomas incorporate a package of features to provide clean air-flow, long life, excellent efficiency, low noise, and low vibration.

Advertisement

Power Supply Provides Targeted Heating And Precision Temperature Control

August 17, 2010 7:05 am | Miyachi Unitek Corp. | Product Releases | Comments

Miyachi Unitek Corp., a leading manufacturer of welding equipment and systems, introduces its Uniflow3 power supply for resistance soldering, heat sealing, and conductive adhesive bonding applications.

Fused Silica Capillary Tubing Can Withstand High Temperatures

August 17, 2010 7:00 am | Product Releases | Comments

Delivering reliable operation in demanding conditions, Fiberguide Industries’ new line of fused silica capillary tubing has proven effective in a number of scientific applications.

TrinityCare Senior Living, Inc. Announces Second Quarter Operating Results

August 17, 2010 2:45 am | by The Associated Press | News | Comments

http://www.trinitycare.com () —TrinityCare Senior Living, Inc. (OTCBB: TCSR) (the "Company"), which develops, manages and owns faith-based senior living facilities, today announced its operating results for the second quarter of 2010.For the six months ended June 30, 2010, the Company reported...

Amarin Corporation Appoints Colin W. Stewart as President and Chief Executive Officer

August 17, 2010 12:33 am | by Bio-Medicine.Org | News | Comments

DUBLIN and MYSTIC, Conn., Aug. 17 /- Amarin Corporation plc (Nasdaq: AMRN ), a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that Colin W. Stewart has been appointed President, Chief Executive Officer (CEO) and a member of the Company's...

TOPICS:

Oridion to Present Results to New Study for the Integrated Pulmonary Index(TM) at ATACCC Conference

August 17, 2010 12:32 am | by Bio-Medicine.Org | News | Comments

Oridion to Present Results to New Study for the Integrated Pulmonary... -- JERUSALEM and NEEDHAM, Massachusetts, August 17, 2010 /-

TOPICS:
Advertisement

Delcath launches stock offering

August 16, 2010 5:45 pm | by The Associated Press | News | Comments

Medical device maker Delcath Systems Inc. said Monday it has started an offering of about 5.2 million shares to raise funds to pay for clinical trials, research and development and other costs.The offering is expected to close Aug. 20.Delcath has granted the underwriter a 30-day option to buy...

IMS Health names Bousbib as new CEO

August 16, 2010 1:45 pm | by The Associated Press | News | Comments

Health-care market intelligence provider IMS Health Inc. on Monday said United Technologies Corp. executive Ari Bousbib will become its chief executive officer on Sept. 1.Bousbib, 48, was most recently president of United Technology's commercial companies, which include Otis Elevator Co. and...

FDA Proposes Withdrawal of Low Blood Pressure Drug

August 16, 2010 1:35 pm | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., Aug. 16 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today proposed to withdraw approval of the drug midodrine hydrochloride, used to treat the low blood pressure condition orthostatic hypotension, because required post-approval studies that verify...

TOPICS:

Midodrine hydrochloride: FDA Proposes Withdrawal of Low Blood Pressure Drug

August 16, 2010 1:31 pm | by U.S. Food & Drug Administration | News | Comments

Companies failed to provide evidence of clinical benefit of midodrine hydrochloride because required post-approval studies that verify the clinical benefit of the drug have not been done.

TOPICS:

Endologix Enters Development Agreement and Exclusive License for Balloon Expandable Stent Technology

August 16, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Aug. 16 /- Endologix, Inc. (Nasdaq: ELGX ), developer of minimally invasive treatments for aortic disorders, announced today that it has entered into a development agreement and exclusive license with Evasc Medical Systems Corp., for its balloon expandable stent...

TOPICS:

Springer adds Neurotherapeutics to journals portfolio

August 16, 2010 10:33 am | by EurekAlert | News | Comments

(Springer) Beginning in 2011, Springer will publish Neurotherapeutics, the official Journal of the American Society for Experimental NeuroTherapeutics. With the switch to Springer, Neurotherapeutics will change its format of publishing review articles only to offering original research...

TOPICS:

PRA International Hosts Audio Conference on CV Drug Development

August 16, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

RALEIGH, N.C., Aug. 16 /- PRA International, a leading Clinical Research Organization, will host an audio conference on strategies for successful cardiovascular (CV) drug development on 24 August 2010 at 11:30 am (EDT). Dr. Michael Kirchengast, Vice President and Head of PRA's Scientific...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading